[PDF][PDF] Dosimetry and toxicity of samarium-153-EDTMP administered for bone pain due to skeletal metastases
JE Bayouth, DJ Macey, LP Kasi… - Journal of Nuclear …, 1994 - Soc Nuclear Med
Skeletal retention was calculated from unnary excretion. Re suits: No uptake of 1@ Sm-
EDTMPin nonskeletaltissues was observed in whole-body gamma camera images. The …
EDTMPin nonskeletaltissues was observed in whole-body gamma camera images. The …
Samarium—153 EDTMP therapy of disseminated skeletal metastasis
JH Turner, AA Martindale, P Sorby… - European journal of …, 1989 - Springer
Abstract 153 Sm-EDTMP (ethylenediaminetetramethylene phosphonate), prepared from a
kit, was administered to 28 patients in a clinical trial of therapy for painful skeletal …
kit, was administered to 28 patients in a clinical trial of therapy for painful skeletal …
[PDF][PDF] Samarium-153-EDTMP: pharmacokinetic, toxicity and pain response using an escalating dose schedule in treatment of metastatic bone cancer
M Farhanghi, RA Holmes, WA Volkert… - Journal of Nuclear …, 1992 - Soc Nuclear Med
I452 The Journalof NuclearMedicine• Vol. 33 • No. 8 • August1992 more of the
following: x-ray,@ mTc@ HDPbone image, Cl'scan, MRI and bone biopsy. The study was …
following: x-ray,@ mTc@ HDPbone image, Cl'scan, MRI and bone biopsy. The study was …
Samarium-153-EDTMP in bone metastases.
A Ahonen, H Joensuu, J Hiltunen… - Journal of Nuclear …, 1994 - europepmc.org
Thirty-five patients with painful bone metastases arising from a variety of tumor types
underwent a clinical trial in which 153Sm-EDTMP was injected as a single intravenous …
underwent a clinical trial in which 153Sm-EDTMP was injected as a single intravenous …
Efficacy and toxicity of Sm-153 EDTMP in the palliative treatment of painful bone metastases
E Olea, P Zhongyun, EP Parma, P Pusuwan… - World Journal of Nuclear …, 2002 - osti.gov
The aim of this multi-centre study was to assess the efficacy and toxicity of Samarium-153
EDTMP (Sm-153 EDTMP) in the palliative treatment of painful skeletal metastases. Four …
EDTMP (Sm-153 EDTMP) in the palliative treatment of painful skeletal metastases. Four …
[153Sm] EDTMP: a potential therapy for bone cancer pain
RA Holmes - Seminars in nuclear medicine, 1992 - Elsevier
Reactor-produced samarium-153 (153 Sm) is both a beta and gamma emitter with a
physical half-life of 46.3 hours. When complexed with EDTMP, more than 50% of the …
physical half-life of 46.3 hours. When complexed with EDTMP, more than 50% of the …
Systemic metabolic radiotherapy with samarium-153 EDTMP for the treatment of painful bone metastasis
AN Serafini - The Quarterly Journal of Nuclear Medicine and …, 2001 - search.proquest.com
Various radioisotopes conjugated to pyrophosphate analogues have been developed for
systemic metabolic radiotherapy. Samarium-153-EDTMP is a 1: 1 complex of radioactive …
systemic metabolic radiotherapy. Samarium-153-EDTMP is a 1: 1 complex of radioactive …
Skeletal uptake and soft-tissue retention of 186Re-HEDP and 153Sm-EDTMP in patients with metastatic bone disease
W Brenner, WU Kampen, AM Kampen… - Journal of Nuclear …, 2001 - Soc Nuclear Med
The aim of this study was to introduce a new quantification method for 153Sm-
ethylenediaminetetramethylenephosphonate (EDTMP) and 186Re-(tin) 1, 1 …
ethylenediaminetetramethylenephosphonate (EDTMP) and 186Re-(tin) 1, 1 …
Samarium-153-EDTMP biodistribution and dosimetry estimation.
JF Eary, C Collins, M Stabin, C Vernon… - Journal of Nuclear …, 1993 - europepmc.org
A comment on this article appears in" Samarium-153-EDTMP dosimetry." J Nucl Med. 1994
Jan; 35 (1): 191-2. A comment on this article appears in" Biodistribution and dosimetry of …
Jan; 35 (1): 191-2. A comment on this article appears in" Biodistribution and dosimetry of …
Dose response relationship and multiple dose efficacy and toxicity of samarium-153-EDTMP in metastatic cancer to bone
AS Alberts, BJ Smit, WKA Louw… - Radiotherapy and …, 1997 - Elsevier
Introduction: The optimal dose of samarium-153-EDTMP (153Sm-EDTMP) for effective
palliation of painful metastases to bone is under investigation. It is not known whether …
palliation of painful metastases to bone is under investigation. It is not known whether …